Active Filters

  • (-) Eawag Departments = Environmental Chemistry UCHEM
  • (-) Publication Year = 2006 - 2018
  • (-) Eawag Authors ≠ Ort, Christoph
  • (-) Journal = Integrated Environmental Assessment and Management
Search Results 1 - 4 of 4
  • RSS Feed
Select Page
Environmental risk assessment of human pharmaceuticals in the European union: a case study with the β-blocker atenolol
Küster, A., Alder, A. C., Escher, B. I., Duis, K., Fenner, K., Garric, J., … Knacker, T. (2010). Environmental risk assessment of human pharmaceuticals in the European union: a case study with the β-blocker atenolol. Integrated Environmental Assessment and Management, 6(1), 514-523. https://doi.org/10.1897/IEAM_2009-050.1
Environmental risk assessment of ivermectin: a case study
Liebig, M., Fernandez, Á. A., Blübaum-Gronau, E., Boxall, A., Brinke, M., Carbonell, G., … Duis, K. (2010). Environmental risk assessment of ivermectin: a case study. Integrated Environmental Assessment and Management, 6(S1), 567-587. https://doi.org/10.1002/ieam.96
Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: case study using the european risk assessment framework
Oakes, K. D., Coors, A., Escher, B. I., Fenner, K., Garric, J., Gust, M., … Servos, M. R. (2010). Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: case study using the european risk assessment framework. Integrated Environmental Assessment and Management, 6(S1), 524-539. https://doi.org/10.1002/ieam.77
Environmental persistence of organic pollutants: guidance for development and review of POP risk profiles
Boethling, R., Fenner, K., Howard, P., Klečka, G., Madsen, T., Snape, J. R., & Whelan, M. J. (2009). Environmental persistence of organic pollutants: guidance for development and review of POP risk profiles. Integrated Environmental Assessment and Management, 5(4), 539-556. https://doi.org/10.1897/IEAM_2008-090.1